To delve deeper into the mechanism by which BAP1 regulates pancreatic cancer’s response to immunotherapy, we analyzed transcriptome data from the TCGA-PAAD dataset, comparing patients with BAP1 deletion to those with diploid or amplified BAP1 expression (Fig. 2A). The gene discussed is BAP1; the disease is pancreatic adenocarcinoma.